Launch of dyslipidemia treatment “Megaroban Soft Capsule 5/1000mg”

 

KyungDong Pharm Co., Ltd. expands its range of dyslipidemia treatment products through the launch of ‘Megaro Semi-Soft Capsule 5/1000mg (hereinafter referred to as Megaro Semi-Soft Capsule)’ on March 1, 2021. Megarovan soft capsule is a combination of Rosuvastatin and Omega-3 acid, a drug that simultaneously controls LDL-cholesterol and triglycerides (TG).

Rosuvastatin is a statin-based ingredient that accounts for the largest portion in the lipid-lowering agent market, and has a high market share of approximately 32% of all statin-based ingredients. Omega-3 fatty acids are effective in controlling neutral fat and preventing cardiovascular disease.

Control of triglycerides is necessary to reduce the risk of cardiovascular disease that remains even when Staitn, which has a strong cholesterol-lowering effect, is administered alone, and Megarovan soft capsules can be of great help in this treatment strategy. In fact, the Korean Society of Lipid and Arteriosclerosis' dyslipidemia treatment guidelines (4th edition) recommend drug treatment with fibrates and omega-3 fatty acids when the triglyceride concentration continues to be over 500 mg/dl (II, A), and when hypertriglyceridemia over 200 mg/dl persists even after lifestyle modification and statin administration, additional administration of fibrates or omega-3s is recommended in addition to the existing statin administration. There is.(II,B)

KyungDong Pharm Co., Ltd. already has a number of products showing top performance in the lipid-lowering drug market. In addition, the release of Megalo semi-soft capsules, which simultaneously control cholesterol and neutral fat, presents a new approach to the market that has not been able to be brought into the scope of KyungDong Pharm Co., Ltd. until now, raising expectations for the expansion of the dyslipidemia treatment market.

 

♠ Product Information ♠

Product name

Megarovan Soft Cap. 5/1000mg

Ingredient content

Rosuvastatin calcium 5.2mg in 1 capsule (5mg as rosuvastatin)

Omega 3 acid ethyl ester 90 1,000mg

Gender

An oblong, white film-coated soft capsule containing a pale yellow oily substance.

Indications

Treatment of mixed type (IIb) dyslipidemia in which LDL-cholesterol levels are adequately controlled but triglyceride levels are not adequately controlled during rosuvastatin monotherapy in adult patients at high risk of coronary heart disease (CHD).

Dosage and usage

2-4 capsules once a day with a meal

How to save

Airtight container, stored at room temperature (1~30℃)

Packaging unit

100 capsules (10 capsules/PTPx10)

Insurance claim code

648104601

Standard drug price

611 won/capsule